Guo, Y., Zhang, Y. (2026). Real-world study on the effect of PARPi as maintenance therapy on recurrent site after first-line chemotherapy in patients with high-grade serous epithelial ovarian cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e17593